Clinical Trials Logo
  1. Home
  2. Neuropathy
  3. NCT03436680

Home-Based Neurofeedback Program in Treating Participants With Chemotherapy-Induced Peripheral Neuropathy

Neuropathy Clinical Trial

Official title:
Feasibility of Home-Based Neurofeedback to Treat Chemotherapy-Induced Peripheral Neuropathy

Clinical Trial Summary

This trial studies how well a home-based neurofeedback program works in treating participants with chemotherapy-induced peripheral neuropathy (nerve damage that affects motor function). Neurofeedback training is a type of therapy that uses an electroencephalograph and a computer software program to measure brain wave activity. It may help teach participants how to change their own brain waves to lower their perception of pain symptoms and improve overall quality of life.

Clinical Trial Description

PRIMARY OBJECTIVES: I. Examine the feasibility of using a home-based neurofeedback system and dry electroencephalography (EEG) cap to treat chemotherapy-induced peripheral neuropathy (CIPN). SECONDARY OBJECTIVES: I. Estimate the effects of home-based neurofeedback (HBNF) on symptoms of (CIPN) versus a wait list (WL) control group in cancer patients. II. Estimate the effects of home-based neurofeedback (HBNF), versus WL, on the cortical and subcortical brain regions associated with CIPN. III. Estimate the effects of a HBNF on other aspects of pain, cancer-related symptoms, quality of life (QOL), and mental health. OUTLINE: Participants are randomized to 1 of 2 groups. GROUP I: Participants complete at least neurofeedback training sessions over 30 minutes 2 times a week for up to 5 weeks. GROUP II: Participants receive standard of care. After completion of study, participants are followed up at 1 week for Group I and 6 weeks for Group II. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03436680
Study type Interventional
Source M.D. Anderson Cancer Center
Contact
Status Withdrawn
Phase N/A
Start date September 1, 2020
Completion date December 31, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT03195868 - Photobiomodulation Therapy and Nerve Density for Patients With Diabetic or Chemotherapy-associated Neuropathy N/A
Not yet recruiting NCT05565469 - Correlation Between Abdominal Wall Stimulation and Neurostimulator Tip Location N/A
Completed NCT02309164 - The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN). N/A
Completed NCT00775645 - S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy Phase 3
Completed NCT03624426 - Detection and Prevention of Nerve Injury in Shoulder Arthroplasty Surgery N/A
Completed NCT05691738 - Effects of Modified Otago Exercises in Individuals With Diabetic Neuropathy N/A
Completed NCT05095870 - Evaluation of the Peripheral Nerve Ultrasound as a Diagnostic Tool in CANVAS Neuropathies
Completed NCT02615678 - Acupuncture for CIPN in Breast Cancer Patients N/A
Completed NCT02011282 - Electro-Neuro-Muscular Stimulation in ICU N/A
Recruiting NCT01774058 - The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation Phase 2
Completed NCT01135251 - Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful Neuropathy Phase 2
Recruiting NCT06324344 - Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy Induced Peripheral Neuropathy (CIPN) N/A
Recruiting NCT04403802 - Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy N/A
Recruiting NCT04579406 - Perioperative Adverse Cardiovascular Event in Type-2 Diabetic Patients
Recruiting NCT03881930 - Balance Rehabilitation With Modified Visual Input in Patients With Neuropathy N/A
Completed NCT03909464 - Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy
Completed NCT01523132 - Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms N/A
Completed NCT02689661 - Impact of the Metabolic Syndrome on the Incidence of Neuropathy in Obese Subjects
Terminated NCT00998738 - Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer Phase 3
Withdrawn NCT00528593 - Epoetin Alfa for HIV-Associated Neuropathy Trial Phase 2